SomaLogic (NASDAQ:SLGC) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 40 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $41.71 million which beat the analyst consensus estimate of $20.07 million by 107.84 percent. This is a 108.65 percent increase over sales of $19.99 million the same period last year.
Japan To Buy Additional 50M Doses Of Moderna COVID-19 Vaccine
Moderna Inc (NASDAQ:MRNA) has announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical Co…
